Sarda Proteins Hits Upper Circuit Amidst Unprecedented Buying Interest

Unprecedented Market Activity in Sarda Proteins

On 24 Nov 2025, Sarda Proteins witnessed a remarkable trading session where the stock opened with a 5.0% gain and immediately touched an intraday high of Rs 69.52. Notably, the stock has traded exclusively at this peak price throughout the day, indicating a complete absence of sellers and a queue filled solely with buy orders. This phenomenon is indicative of a strong bullish sentiment and a potential upper circuit lock-in, which could extend over multiple trading sessions if the buying pressure persists.

The stock’s performance today outpaced the broader Sensex, which recorded a marginal gain of 0.05%. Sarda Proteins outperformed its edible oil sector peers by 5.19%, underscoring the intensity of demand specific to this stock.

Recent Price Momentum and Trading Patterns

Sarda Proteins has been on a positive trajectory over the last two days, delivering cumulative returns of 10.24%. This consecutive gain highlights a shift in market dynamics after a period of subdued activity. However, the stock’s trading history over the past month and quarter shows a contrasting picture, with declines of 37.79% and 49.42% respectively, reflecting volatility and erratic trading patterns.

Interestingly, the stock did not trade on one day out of the last 20 sessions, which may have contributed to pent-up demand culminating in today’s surge. The opening gap up of 5% today further emphasises the eagerness of buyers to accumulate shares at higher price levels.

Technical Indicators and Moving Averages

From a technical standpoint, Sarda Proteins is trading above its 5-day and 200-day moving averages, which often signals short-term and long-term support levels. However, it remains below the 20-day, 50-day, and 100-day moving averages, suggesting that while immediate momentum is positive, the stock has yet to fully recover from its recent downtrend over intermediate periods.

This mixed technical picture may contribute to the current volatility and the strong buying interest as investors weigh the stock’s potential for recovery against its recent performance challenges.

Long-Term Performance Context

Examining Sarda Proteins’ longer-term performance reveals a complex narrative. Over the past year and year-to-date periods, the stock has shown no net change, contrasting with the Sensex’s gains of 7.79% and 9.14% respectively. The three-year performance shows a significant decline of 61.44%, while the five-year returns stand out positively at 631.79%, far exceeding the Sensex’s 91.54% over the same period.

These figures illustrate a stock that has experienced substantial volatility and cyclical shifts, with periods of strong growth offset by recent challenges. The zero returns over the last decade, compared to the Sensex’s 230.84% rise, further highlight the stock’s uneven trajectory.

Sector and Industry Positioning

Sarda Proteins operates within the edible oil industry, a sector that has seen varied performance influenced by commodity price fluctuations, regulatory changes, and demand-supply dynamics. The stock’s recent outperformance relative to the sector today suggests a renewed investor focus, possibly driven by company-specific developments or broader market sentiment shifts.

Given the edible oil sector’s sensitivity to global and domestic factors, the current buying frenzy in Sarda Proteins may reflect expectations of favourable conditions or strategic moves by the company that have yet to be fully reflected in its longer-term price trends.

Implications of the Upper Circuit Scenario

The presence of only buy orders and the stock’s immediate lock at the upper circuit price is a rare occurrence that often signals strong market conviction. This scenario can lead to a multi-day upper circuit if the demand continues unabated and no sellers emerge to absorb the buying interest.

For investors and market participants, such a situation warrants close monitoring. While it reflects enthusiasm and potential positive sentiment, it also introduces challenges related to liquidity and price discovery. The absence of sellers can lead to price stagnation at the circuit limit, limiting trading opportunities and potentially increasing volatility once the circuit is lifted.

Market analysts will be watching closely to see if this buying momentum sustains, potentially signalling a turnaround in the stock’s recent performance or if it represents a short-term speculative spike.

Conclusion: A Stock Under the Spotlight

Sarda Proteins’ current trading session stands out as a significant event in the edible oil sector, marked by extraordinary buying interest and an upper circuit lock. The stock’s recent consecutive gains and outperformance relative to the Sensex and sector peers highlight a shift in market dynamics that could influence its near-term trajectory.

However, the mixed signals from its longer-term performance and technical indicators suggest that investors should approach with a balanced perspective, considering both the potential for continued momentum and the risks associated with erratic trading patterns.

As the market digests this unusual activity, Sarda Proteins remains a stock to watch closely for further developments in price action and trading behaviour.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →